Skip to content

Vor Biopharma VOR Warrant Liabilities Noncurrent

Warrant Liabilities Noncurrent at other companies

NextNav logo
NextNavNN
$29.74M+38.8%
Gryphon Digital Mining, Inc. logo
Gryphon Digital Mining, Inc.ABTC
$77K
Enovix Corporation logo
Enovix CorporationENVX
$0-100%
Butterfly Network logo
Butterfly NetworkBFLY
$0-100%
Archer Aviation logo
Archer AviationACHR
$7.1M-85.1%
Enovix Corporation logo
Enovix CorporationENVX
$181K

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,513%
Enterprise value$617.68M+5,639%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept vor:WarrantLiabilitiesNoncurrent.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's warrant liabilities noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's warrant liabilities noncurrent?
Vor Biopharma (VOR) reported warrant liabilities noncurrent of $638.46M in Q1 2026.
What does warrant liabilities noncurrent mean?
This represents the fair value of outstanding warrants classified as long-term liabilities that are expected to be settled beyond the next twelve months. These instruments often arise from equity financing activities and are subject to periodic revaluation based on changes in the company's stock price and volatility. Investors track this metric to understand potential future dilution and the impact of non-cash accounting adjustments on the company's long-term balance sheet stability.